CA2231557A1 - Compositions a base de melatonine et d'antalgiques et utilisations - Google Patents

Compositions a base de melatonine et d'antalgiques et utilisations Download PDF

Info

Publication number
CA2231557A1
CA2231557A1 CA002231557A CA2231557A CA2231557A1 CA 2231557 A1 CA2231557 A1 CA 2231557A1 CA 002231557 A CA002231557 A CA 002231557A CA 2231557 A CA2231557 A CA 2231557A CA 2231557 A1 CA2231557 A1 CA 2231557A1
Authority
CA
Canada
Prior art keywords
melatonin
sleep
analgetic
administered
effective dose
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002231557A
Other languages
English (en)
Inventor
Richard J. Wurtman
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Indevus Pharmaceuticals Inc
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to EP95933966A priority Critical patent/EP0854713A4/fr
Priority to PCT/US1995/012369 priority patent/WO1997012612A1/fr
Priority to AU36432/95A priority patent/AU3643295A/en
Priority to CA002231557A priority patent/CA2231557A1/fr
Publication of CA2231557A1 publication Critical patent/CA2231557A1/fr
Priority to NO981489A priority patent/NO981489L/no
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/60—Salicylic acid; Derivatives thereof
    • A61K31/618—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate
    • A61K31/621—Salicylic acid; Derivatives thereof having the carboxyl group in position 1 esterified, e.g. salsalate having the hydroxy group in position 2 esterified, e.g. benorylate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention concerne des compositions à base de mélatonine et d'un (ou plusieurs) antalgique. L'invention concerne également des procédés d'administration de mélatonine et d'un (ou plusieurs) antalgique pour soulager la douleur et induire le sommeil.
CA002231557A 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations Abandoned CA2231557A1 (fr)

Priority Applications (5)

Application Number Priority Date Filing Date Title
EP95933966A EP0854713A4 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations
PCT/US1995/012369 WO1997012612A1 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations
AU36432/95A AU3643295A (en) 1995-10-03 1995-10-03 Compositions of melatonin and analgetic agents and methods of use thereof
CA002231557A CA2231557A1 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations
NO981489A NO981489L (no) 1995-10-03 1998-04-02 Blandinger av melatonin og analgetika samt anvendelser derav

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
PCT/US1995/012369 WO1997012612A1 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations
CA002231557A CA2231557A1 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations

Publications (1)

Publication Number Publication Date
CA2231557A1 true CA2231557A1 (fr) 1997-04-10

Family

ID=25680080

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002231557A Abandoned CA2231557A1 (fr) 1995-10-03 1995-10-03 Compositions a base de melatonine et d'antalgiques et utilisations

Country Status (3)

Country Link
EP (1) EP0854713A4 (fr)
CA (1) CA2231557A1 (fr)
WO (1) WO1997012612A1 (fr)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000500159A (ja) * 1996-05-20 2000-01-11 フイズ テクノロジーズ リミテッド メラトニンと組み合わせた鎮痛剤
MX346273B (es) * 2012-12-19 2017-02-15 Cecype Services S De R L De C V Composición farmacéutica que comprende la combinación de un agente antiinflamatorio no esteroideo, un agente adyuvante y un analgésico antineurítico, con efecto antinociceptivo.
WO2018130865A1 (fr) * 2017-01-13 2018-07-19 The Hospital For Sick Children Traitement des maux de tête chez les enfants et procédé

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3466215D1 (en) * 1983-05-18 1987-10-22 Univ Monash The use of melatonin for the manufacture of a medicament
US4687763A (en) * 1985-02-25 1987-08-18 Massachusetts Institute Of Technology Composition and method for increasing levels or release of brain serotonin
US5688520A (en) * 1995-03-29 1997-11-18 Minnesota Mining And Manufacturing Company Transmucosal delivery of melatonin for prevention of migraine
FR2741799B1 (fr) * 1995-12-04 1998-01-02 Oreal Utilisation de melatonine dans une composition pour traiter les signes cutanes des etats de fatigue
JP2000500159A (ja) * 1996-05-20 2000-01-11 フイズ テクノロジーズ リミテッド メラトニンと組み合わせた鎮痛剤

Also Published As

Publication number Publication date
EP0854713A4 (fr) 1999-01-07
EP0854713A1 (fr) 1998-07-29
WO1997012612A1 (fr) 1997-04-10

Similar Documents

Publication Publication Date Title
JP3712420B2 (ja) ５―ｈｔアゴニストの処方物
Jonas et al. The use of opiate antagonists in treating bulimia: a study of low-dose versus high-dose naltrexone
EP0426479B1 (fr) Utilisation d'une compostition pour la fabrication d'un médicament destiné à traiter les symptômes de l'intempérance
Halpern Analgesic drugs in the management of pain
Krishnan et al. Psyche, opioids, and itch: therapeutic consequences
JPS59193821A (ja) 抗不安薬としてのフルオキセチンの使用法
JP4521117B2 (ja) 偏頭痛、群発性頭痛、緊張性頭痛、血管疾患に伴う頭痛、耳鳴りまたは筋肉性頭痛を治療するための医薬
US20030008005A1 (en) Sublingual administration of dihydroergotamine for the treatment of migraine
CA2379752C (fr) Utilisation d'agonistes de recepteurs gabab et de leurs derives acceptables sur le plan pharmaceutique dans la therapie de maintien de l'abstinence a la nicotine chez les patientsdependants de la nicotine
US11744833B2 (en) Pharmaceutical compositions and methods for treatment of insomnia
US4479956A (en) Analgesic compositions comprising propiram and methods of using same
CA2231557A1 (fr) Compositions a base de melatonine et d'antalgiques et utilisations
WO2023158424A1 (fr) Nouvelles compositions pharmaceutiques et méthodes de traitement de l'insomnie
AU2001218105B2 (en) Behavior chemotherapy
JP2000500159A (ja) メラトニンと組み合わせた鎮痛剤
MXPA98002735A (en) Compositions of melatonine and analgesic agents and methods of use of the mis
JP2000509012A (ja) メラトニンおよび鎮痛剤の組成物およびその使用法
JPH06509073A (ja) 光学的に純粋なｓ（−）オンダンセトロンを使用する嘔吐、吐き気および他の障害の治療のための方法および組成物
Schwartz Perioperative pain management
Shapiro et al. Perioperative pain control
Houglum et al. Drugs for Treating Pain
Ives et al. Short-course diphenoxylate hydrochloride for treatment of methadone withdrawal symptoms
US20080081798A1 (en) Pharmaceutical combinations for the treatment of head-aches and migraine attacks as well as blisters and packs that contain them
JP2006076945A (ja) 線維筋痛症候群の治療剤
Sacks The use of an isopyrine-phenylbutazone compound in migraine

Legal Events

Date Code Title Description
FZDE Dead